Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 18th:
Splunk Inc. : This software solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
Splunk’s shares gained 14.5% over the last one month in contrast with the S&P 500’s decrease of 3.6%. The company possesses a Momentum Score of A.
KCAP Financial, Inc. : This business development company that specializes in investments has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.
KCAP Financial’s shares gained 3% over the last one month. The company possesses a Momentum Score of B.
COUPA SOFTWARE : This cloud-based spend management platform provider has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 42.8% over the last 60 days.
COUPA SOFTWARE’s shares gained 9.62% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 18th:
Splunk Inc. : This software solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
Splunk’s shares gained 14.5% over the last one month in contrast with the S&P 500’s decrease of 3.6%. The company possesses a Momentum Score of A.
KCAP Financial, Inc. : This business development company that specializes in investments has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.
KCAP Financial’s shares gained 3% over the last one month. The company possesses a Momentum Score of B.
COUPA SOFTWARE : This cloud-based spend management platform provider has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 42.8% over the last 60 days.
COUPA SOFTWARE’s shares gained 9.62% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>